Literature DB >> 9858324

The epidemiology of prostate cancer part I: descriptive epidemiology.

O W Brawley1, K Knopf, R Merrill.   

Abstract

The incidence and mortality of prostate cancer is highly varied among populations and especially among blacks and whites. The incidence rates of all American populations have dramatically changed over the past 25 years. The recent increase in incidence has been attributed to prostate cancer screening. Although the incidence has increased over the past 25 years, the mortality rates although vastly different between populations have remained rather stable within populations. Prostate cancer is still a disease that primarily afflicts older men. The median age at diagnosis is 71 years for whites and 69 years for blacks. More than 80% are over the age of 65 years. Screening for prostate cancer has dramatically increased the number of men with local disease at diagnosis, but it is unclear whether screening and aggressive treatment have caused a decrease in mortality.

Entities:  

Mesh:

Year:  1998        PMID: 9858324

Source DB:  PubMed          Journal:  Semin Urol Oncol        ISSN: 1081-0943


  10 in total

1.  Serum prostate-specific antigen levels in older men with or at risk of HIV infection.

Authors:  L E Vianna; Y Lo; R S Klein
Journal:  HIV Med       Date:  2006-10       Impact factor: 3.180

2.  Healthcare access, socioeconomic factors and late-stage cancer diagnosis: an exploratory spatial analysis and public policy implication.

Authors:  Fahui Wang; Lan Luo; Sara McLafferty
Journal:  Int J Public Pol       Date:  2009-12-28

3.  Race and the likelihood of localized prostate cancer at diagnosis among men in 4 southeastern states.

Authors:  Mohammed Norman Oliver; George J Stukenborg
Journal:  J Natl Med Assoc       Date:  2009-08       Impact factor: 1.798

4.  A first-generation multiplex biomarker analysis of urine for the early detection of prostate cancer.

Authors:  Bharathi Laxman; David S Morris; Jianjun Yu; Javed Siddiqui; Jie Cao; Rohit Mehra; Robert J Lonigro; Alex Tsodikov; John T Wei; Scott A Tomlins; Arul M Chinnaiyan
Journal:  Cancer Res       Date:  2008-02-01       Impact factor: 12.701

5.  Cancer incidence in the south Asian population of California, 1988-2000.

Authors:  Ratnali V Jain; Paul K Mills; Arti Parikh-Patel
Journal:  J Carcinog       Date:  2005-11-10

6.  Race-specific geography of prostate cancer incidence.

Authors:  Laurie M DeChello; David I Gregorio; Holly Samociuk
Journal:  Int J Health Geogr       Date:  2006-12-18       Impact factor: 3.918

Review 7.  Circulating Long Noncoding RNA as a Potential Target for Prostate Cancer.

Authors:  Yin-Jie Su; Jin Yu; Ya-Qin Huang; Jin Yang
Journal:  Int J Mol Sci       Date:  2015-06-11       Impact factor: 5.923

Review 8.  Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia.

Authors:  Yasuhide Kitagawa; Mikio Namiki
Journal:  Asian J Androl       Date:  2015 May-Jun       Impact factor: 3.285

Review 9.  Kallikreins as biomarkers for prostate cancer.

Authors:  Sung Kyu Hong
Journal:  Biomed Res Int       Date:  2014-04-07       Impact factor: 3.411

10.  Annual report to the nation on the status of cancer, 1975-2005, featuring trends in lung cancer, tobacco use, and tobacco control.

Authors:  Ahmedin Jemal; Michael J Thun; Lynn A G Ries; Holly L Howe; Hannah K Weir; Melissa M Center; Elizabeth Ward; Xiao-Cheng Wu; Christie Eheman; Robert Anderson; Umed A Ajani; Betsy Kohler; Brenda K Edwards
Journal:  J Natl Cancer Inst       Date:  2008-11-25       Impact factor: 13.506

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.